Arteriosclerosis

动脉硬化
  • 文章类型: Journal Article
    研究稳态模型评估的胰岛素抵抗指数(HOMA-IR)与血管损伤之间关系的大规模人群研究相对缺乏。因此,我们评估了中国18岁及以上成人中HOMA-IR与血管损害之间的关系.总共包括17,985个研究对象。测量血管损伤标志物和相关实验室测试。HOMA-IR计算为(空腹胰岛素*空腹血糖)/22.5。血管损害包括动脉硬化(ba-PWV>1800cm/s),外周动脉疾病(ABI<0.9),和微量白蛋白尿(UACR>30mg/g)。使用RCS分析HOMA-IR与血管损伤之间的关系。受限三次样条(RCS)分析提示HOMA-IR与动脉硬化呈非线性相关(P表示非线性<0.01),外周动脉疾病(无衬垫P<0.01),和微量白蛋白尿(P<0.01)。进一步的分段回归分析显示,在HOMA-IR<5的研究对象中,我们发现HOMA-IR与动脉硬化的OR增加有关(OR:1.36,95%CI(1.28,1.45),P<0.01),外周动脉疾病(OR:1.33,95%CI(1.10,1.60),P<0.01)和微量白蛋白尿(OR:1.59,95%CI(1.49,1.70),P<0.01)。HOMA-IR是血管损伤的独立危险因素,大血管和微血管。HOMA-IR饱和与血管损伤的现象需要进一步研究。
    There is a relative scarcity of large-scale population studies investigating the relationship between the insulin resistance index of homeostasis model assessment (HOMA-IR) and vascular damage. Therefore, we assessed the association between HOMA-IR and vascular damage in adults aged 18 years and older in China. A total of 17,985 research subjects were included. Vascular damage markers and relevant laboratory tests were measured. HOMA-IR was calculated as (fasting insulin * fasting blood glucose)/22.5. Vascular damage included arteriosclerosis (ba-PWV > 1800 cm/s), peripheral artery disease (ABI < 0.9), and microalbuminuria (UACR > 30 mg/g). The relationship between HOMA-IR and vascular damage was analyzed using the RCS. The restricted cubic spline (RCS) analysis suggested that HOMA-IR was nonlinearly associated with arteriosclerosis (P for no-liner < 0.01), peripheral artery disease (P for no-liner < 0.01), and microalbuminuria (P for no-liner < 0.01). Further segmented regression analyses revealed that in study subjects with HOMA-IR < 5, we found that HOMA-IR was associated with an increased OR for arteriosclerosis (OR: 1.36, 95% CI (1.28, 1.45), P < 0.01), peripheral artery disease (OR: 1.33, 95% CI (1.10, 1.60), P < 0.01) and microalbuminuria (OR: 1.59, 95% CI (1.49, 1.70), P < 0.01). HOMA-IR is an independent risk factor for vascular damage, both macrovascular and microvascular. The phenomenon of saturation of HOMA-IR with vascular damage needs further investigation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:经皮肾活检(PKB)使肾脏病学家能够做出治疗各种肾脏疾病的明智决定;然而,应考虑出血并发症的风险,考虑到肾脏的血管。许多研究报道了PKB后出血事件的危险因素。然而,而尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)是肾脏疾病严重程度的有用生物标志物,关于尿NAG是否与出血风险相关的问题知之甚少.
    方法:回顾性研究了2018年10月至2023年10月在国防科技大学医院接受PKB的患者的病历。血红蛋白(Hb)丢失≥1g/dL定义为出血事件。
    结果:在213名患者中,110(51.6%)是男性,中位年龄为56岁(四分位距40-71)。PKB最常见的诊断是IgA肾病(N=72;34.0%)。54例患者(25.3%)在PKB后出现Hb损失≥1g/dL,活检前的尿NAG/Cr水平能够预测出血事件,接收器工作特性曲线下的面积为0.65(p=0.005)。使用35U/gCr的最佳截止值,通过多元logistic回归分析发现尿NAG/Cr是独立的危险因素(比值比3.21,95%置信区间1.42-7.27,p=0.005).即使在调整了以前报告的风险因素后,尿NAG/Cr比值升高仍然是一个有统计学意义的变量.与病理结果相比,只有肌肉小动脉多层弹性层的严重程度与尿NAG/Cr水平(p=0.008)和出血事件(p=0.03)相关.
    结论:尿NAG不仅成功预测了肾脏疾病的严重程度,而且还预测了PKB后的出血事件。肾脏中的动脉硬化可能是这些出血事件增加的潜在机制。
    BACKGROUND: A percutaneous kidney biopsy (PKB) allows nephrologists to make informed decisions for treating various kidney diseases; however, the risk of bleeding complications should be considered, given the vascularity of the kidney. Many studies have reported risk factors for bleeding events after a PKB. However, while urinary N-acetyl-β-D-glucosaminidase (NAG) is a useful biomarker of kidney disease severity, little is known about whether or not urinary NAG is related to the bleeding risk.
    METHODS: Medical records of patients who underwent a PKB at the National Defense Medical College Hospital between October 2018 and October 2023 were retrospectively studied. Hemoglobin (Hb) loss ≥ 1 g/dL was defined as a bleeding event.
    RESULTS: Of the 213 patients, 110 (51.6%) were men, and the median age was 56 years old (interquartile range 40-71). The most frequent diagnosis on a PKB was IgA nephropathy (N = 72; 34.0%). Fifty-four patients (25.3%) experienced Hb loss ≥ 1 g/dL after a PKB, and urinary NAG/Cr levels before the biopsy were able to predict a bleeding event, with an area under the receiver operating characteristic curve of 0.65 (p = 0.005). Using the optimal cutoff value of 35 U/gCr, urinary NAG/Cr was found to be an independent risk factor by multiple logistic regression analysis (odds ratio 3.21, 95% confidence interval 1.42-7.27, p = 0.005). Even after adjusting for previously-reported risk factors, the elevated urinary NAG/Cr ratio remained a statistically significant variable. Compared with the pathological findings, only the severity of multilayered elastic laminae of the small muscular artery was associated with both urinary NAG/Cr levels (p = 0.008) and bleeding events (p = 0.03).
    CONCLUSIONS: Urinary NAG successfully predicted not only the severity of kidney disorders but also bleeding events after a PKB. Arteriosclerosis in the kidneys may be the mechanism underlying these increased bleeding events.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    (1)背景:眼底检查是评估人体血管状态的最佳和流行方法之一。通过检眼镜直接观察视网膜血管已经用于判断高血压改变或动脉硬化。最近,非散瞳扫描激光检眼镜(SLO)的眼底成像由于具有光学相干断层扫描或使用造影剂染料的血管造影的多模态功能,已广泛应用于眼科诊所.这项研究的目的是检查在SLO图像中检测视网膜血管动脉硬化的实用性;(2)方法:回顾性检查了糖尿病性视网膜病变(DR)眼睛的彩色和蓝色标准视野SLO图像。彩色SLO图像中的视网膜动脉硬化根据Scheie分类进行分级。此外,对蓝色SLO图像中的视网膜小动脉的特征进行了鉴定,并检查了它们与动脉硬化等级的相关性,DR分期或一般并发症;(3)结果:相对于彩色眼底图像,蓝色SLO图像显示在单调背景下明显的高反射视网膜小动脉。在严重动脉硬化患者的眼中,经常观察到蓝色SLO图像中发现的视网膜小动脉不规则(3级:79.0%和4级:81.8%)。此外,小动脉的发现与肾功能不全的DR患者的眼睛有关(p<0.05);(4)结论:虽然彩色SLO图像在评估视网膜动脉硬化方面与摄影或检眼镜一样有用,相应的蓝色SLO图像显示在单调背景下具有高对比度的动脉硬化性病变。晚期或晚期DR眼中的视网膜动脉硬化经常在蓝色图像中显示视网膜小动脉不规则。低的发现,不均匀,蓝色或不连续衰减比彩色SLO图像更容易找到。因此,蓝色SLO图像可以显示视网膜小动脉的病理性微硬化,是糖尿病患者血管评估的安全实用方法之一.
    (1) Background: The fundus examination is one of the best and popular methods in the assessment of vascular status in the human body. Direct viewing of retinal vessels by ophthalmoscopy has been utilized in judging hypertensive change or arteriosclerosis. Recently, fundus imaging with the non-mydriatic scanning laser ophthalmoscope (SLO) has been widely used in ophthalmological clinics since it has multimodal functions for optical coherence tomography or angiography with contrast agent dye. The purpose of this study was to examine the utility in detecting arteriosclerosis of retinal vessels in SLO images; (2) Methods: Both color and blue standard field SLO images of eyes with diabetic retinopathy (DR) were examined retrospectively. Retinal arteriosclerosis in color SLO images was graded according to the Scheie classification. Additionally, characteristics of retinal arterioles in blue SLO images were identified and examined for their relevance to arteriosclerosis grades, stages of DR or general complications; (3) Results: Relative to color fundus images, blue SLO images showed distinct hyper-reflective retinal arterioles against a monotone background. Irregularities of retinal arterioles identified in blue SLO images were frequently observed in the eyes of patients with severe arteriosclerosis (Grade 3: 79.0% and Grade 4: 81.8%). Furthermore, the findings on arterioles were more frequently associated with the eyes of DR patients with renal dysfunction (p < 0.05); (4) Conclusions: While color SLO images are equally as useful in assessing retinal arteriosclerosis as photography or ophthalmoscopy, the corresponding blue SLO images show arteriosclerotic lesions with high contrast in a monotone background. Retinal arteriosclerosis in eyes of advanced grades or advanced DR frequently show irregularities of retinal arterioles in the blue images. The findings of low, uneven, or discontinuous attenuation were easier to find in blue than in color SLO images. Consequently, blue SLO images can show pathological micro-sclerosis in retinal arterioles and are potentially one of the safe and practical methods for the vascular assessment of diabetic patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    机构支持对于所有教师的成功职业发展至关重要,尤其是那些女性。从过去演变,许多机构普遍存在性别差异,近几十年来,在支持女性教师在科学和学术医学领域的职业发展方面取得了重大进展。然而,由于出现了以前未认识到的需求和新的改进机会,因此需要继续发展。为了确定需求,机遇,以及女教师遇到的潜在挑战,动脉硬化妇女领导委员会,血栓形成,血管生物学理事会制定了一项名为“增长”(为技术和健康领域的妇女创造资源和机会)的倡议。该委员会设计了一份调查问卷,并采访了来自美国各地区总共12个机构的19位在教师发展中具有角色和责任的领导者。结果被汇编,分析,并讨论。根据我们的采访和分析,我们介绍了这些代表性机构在支持教师发展方面的现状,强调女性教师特有的努力。通过经验,见解,以及这些领导人的愿景,我们确定了成功的故事,挑战,和未来的优先事项。我们的文章提供了支持提高女教师地位的机构努力的入门和快照。重要的是,这篇文章可以作为学术实体的参考和资源,寻求想法,以衡量他们对女性教师的承诺水平,并实施新的举措。此外,这篇文章可以为女性教师提供指导和策略,因为她们在寻求新的职业机会时从目前或未来的机构寻求支持和资源。
    Institutional support is crucial for the successful career advancement of all faculty but in particular those who are women. Evolving from the past, in which gender disparities were prevalent in many institutions, recent decades have witnessed significant progress in supporting the career advancement of women faculty in science and academic medicine. However, continued advancement is necessary as previously unrecognized needs and new opportunities for improvement emerge. To identify the needs, opportunities, and potential challenges encountered by women faculty, the Women\'s Leadership Committee of the Arteriosclerosis, Thrombosis, and Vascular Biology Council developed an initiative termed GROWTH (Generating Resources and Opportunities for Women in Technology and Health). The committee designed a survey questionnaire and interviewed 19 leaders with roles and responsibilities in faculty development from a total of 12 institutions across various regions of the United States. The results were compiled, analyzed, and discussed. Based on our interviews and analyses, we present the current status of these representative institutions in supporting faculty development, highlighting efforts specific to women faculty. Through the experiences, insights, and vision of these leaders, we identified success stories, challenges, and future priorities. Our article provides a primer and a snapshot of institutional efforts to support the advancement of women faculty. Importantly, this article can serve as a reference and resource for academic entities seeking ideas to gauge their commitment level to women faculty and to implement new initiatives. Additionally, this article can provide guidance and strategies for women faculty as they seek support and resources from their current or prospective institutions when pursuing new career opportunities.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    动脉硬化是心血管疾病的主要致病因素。本研究旨在探讨急性失代偿性心力衰竭(ADHF)患者血浆致动脉粥样硬化指数(AIP)与30天死亡率的相关性。
    从2019年至2022年的江西急性失代偿性心力衰竭1(JX-ADHF1)队列中招募的1,248例ADHF患者被选入本研究。主要结果是30天死亡率。多变量Cox回归,受限三次样条(RCS),采用分层分析评估ADHF患者AIP与30天死亡率之间的关系.中介模型用于探索性分析炎症的作用,氧化应激,和营养在AIP和ADHF患者30天死亡率之间的关联。
    在30天随访期间,42例(3.37%)ADHF患者死亡。对应于AIP四分位数的死亡率如下:Q1:1.28%,Q2:2.88%,Q3:2.88%,Q4:6.41%。多变量Cox回归显示高AIP与ADHF患者30天死亡率呈正相关[危险比(HR)3.94,95%置信区间(CI):1.08-14.28],独立于年龄,性别,心力衰竭类型,心功能分类,和合并症。值得注意的是,在第四个四分位数之前,AIP(<0.24)和30天死亡率之间存在U形曲线关联。ADHF患者30天死亡风险最低,AIP为-0.1左右。此外,中介分析提示炎症和营养对与AIP相关的ADHF患者30天死亡率有显著的中介作用,其中炎症约占24.29%,营养约占8.16%的调解作用。
    这项回顾性队列分析首次揭示了AIP与ADHF患者30天死亡率之间的关联。根据我们的发现,从医学角度来看,维持ADHF患者的AIP在-0.1左右对于改善不良预后至关重要.此外,对于高AIP的ADHF患者,重要的是要评估,如有必要,加强营养支持和抗炎治疗。
    UNASSIGNED: Arteriosclerosis is a primary causative factor in cardiovascular diseases. This study aims to explore the correlation between the atherogenic index of plasma (AIP) and the 30-day mortality rate in patients with acute decompensated heart failure (ADHF).
    UNASSIGNED: A total of 1,248 ADHF patients recruited from the Jiangxi-Acute Decompensated Heart Failure1 (JX-ADHF1) cohort between 2019 and 2022 were selected for this study. The primary outcome was the 30-day mortality rate. Multivariable Cox regression, restricted cubic splines (RCS), and stratified analyses were utilized to assess the relationship between AIP and the 30-day mortality rate in ADHF patients. Mediation models were employed for exploratory analysis of the roles of inflammation, oxidative stress, and nutrition in the association between AIP and the 30-day mortality rate in ADHF patients.
    UNASSIGNED: During the 30-day follow-up, 42 (3.37%) of the ADHF patients died. The mortality rates corresponding to the quartiles of AIP were as follows: Q1: 1.28%, Q2: 2.88%, Q3: 2.88%, Q4: 6.41%. The multivariable Cox regression revealed a positive correlation between high AIP and the 30-day mortality rate in ADHF patients [Hazard ratio (HR) 3.94, 95% confidence interval (CI): 1.08-14.28], independent of age, gender, heart failure type, cardiac function classification, and comorbidities. It is important to note that there was a U-shaped curve association between AIP (<0.24) and the 30-day mortality rate before the fourth quartile, with the lowest 30-day mortality risk in ADHF patients around an AIP of -0.1. Furthermore, mediation analysis suggested significant mediating effects of inflammation and nutrition on the 30-day mortality rate in ADHF patients related to AIP, with inflammation accounting for approximately 24.29% and nutrition for about 8.16% of the mediation effect.
    UNASSIGNED: This retrospective cohort analysis reveals for the first time the association between AIP and the 30-day mortality rate in ADHF patients. According to our findings, maintaining an AIP around -0.1 in ADHF patients could be crucial for improving poor prognoses from a medical perspective. Additionally, for ADHF patients with high AIP, it is important to assess and, if necessary, enhance nutritional support and anti-inflammatory treatment.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    血管老化是随着年龄的增长自然发生的动脉结构和功能的恶化。并且可以随着疾病而加速。血管老化的测量正在成为心血管风险的标志,在疾病诊断和预后方面具有潜在的应用,和指导治疗。然而,在临床实践中尚未对血管老化进行常规评估.实现这一目标的关键一步是开发评估血管老化的技术。在这个路线图中,专家们讨论了这个过程的几个方面,包括:测量技术;开发管道;临床应用;以及未来的研究方向。路线图总结了最新技术,概述了需要克服的主要挑战,并确定未来潜在的研究方向来应对这些挑战。
    Vascular ageing is the deterioration of arterial structure and function which occurs naturally with age, and which can be accelerated with disease. Measurements of vascular ageing are emerging as markers of cardiovascular risk, with potential applications in disease diagnosis and prognosis, and for guiding treatments. However, vascular ageing is not yet routinely assessed in clinical practice. A key step towards this is the development of technologies to assess vascular ageing. In this Roadmap, experts discuss several aspects of this process, including: measurement technologies; the development pipeline; clinical applications; and future research directions. The Roadmap summarises the state of the art, outlines the major challenges to overcome, and identifies potential future research directions to address these challenges.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    衰老在脑小血管病(CSVD)的发病机制中起着举足轻重的作用,有助于血管性认知障碍和痴呆(VCID)的发作和进展。在老年人中,CSVD通常导致显著的病理结果,包括血脑屏障(BBB)破坏,进而引发神经炎症和白质损伤。在神经影像学研究中,这种损伤经常被观察为白质高强度(WMHs)。越来越多的证据表明,患有动脉粥样硬化血管疾病的老年人,比如外周动脉疾病,缺血性心脏病,颈动脉狭窄,面临发展CSVD和VCID的风险增加。本文综述了外周动脉粥样硬化与动脉粥样硬化的复杂关系,CSVD的发病机制,和BBB中断。它探索了血管老化的连续性,强调大动脉粥样硬化和脑微循环BBB破坏的共同病理机制,同时加重CSVD和VCID。通过审查目前的证据,本文讨论了内皮功能障碍的影响,细胞衰老,炎症,和氧化应激对血管和神经血管健康的影响。这篇综述旨在加强对这些复杂相互作用的理解,并倡导综合方法来管理血管健康。从而降低CSVD和VCID的风险和进展。
    Aging plays a pivotal role in the pathogenesis of cerebral small vessel disease (CSVD), contributing to the onset and progression of vascular cognitive impairment and dementia (VCID). In older adults, CSVD often leads to significant pathological outcomes, including blood-brain barrier (BBB) disruption, which in turn triggers neuroinflammation and white matter damage. This damage is frequently observed as white matter hyperintensities (WMHs) in neuroimaging studies. There is mounting evidence that older adults with atherosclerotic vascular diseases, such as peripheral artery disease, ischemic heart disease, and carotid artery stenosis, face a heightened risk of developing CSVD and VCID. This review explores the complex relationship between peripheral atherosclerosis, the pathogenesis of CSVD, and BBB disruption. It explores the continuum of vascular aging, emphasizing the shared pathomechanisms that underlie atherosclerosis in large arteries and BBB disruption in the cerebral microcirculation, exacerbating both CSVD and VCID. By reviewing current evidence, this paper discusses the impact of endothelial dysfunction, cellular senescence, inflammation, and oxidative stress on vascular and neurovascular health. This review aims to enhance understanding of these complex interactions and advocate for integrated approaches to manage vascular health, thereby mitigating the risk and progression of CSVD and VCID.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Objective: To study the relationship between hemoglobin glycation index (HGI) and blood lipid indices such as low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C), and plasma atherogenic index (AIP). Methods: This cross-sectional study included 16 049 participants from the Beijing Apple Garden community between December 2011 and August 2012. The subjects were divided into three groups based on the HGI quartile: low (n=5 388), medium (n=5 249), and high (n=5 412). The differences in blood lipid indicators between different HGI groups were compared and multivariate logistic regression model was established to analyze the association between HGI and dyslipidemia. And multivariate logistic regression model was established to analyze the relationship between HGI and blood lipid indicators in different glucose metabolism populations. Results: There were 16 049 participants in all (mean age: 56 years), including 10 452 women (65.1%). They were classified into normal glucose tolerance (9 093 cases), prediabetes (4 524 cases), and diabetes (2 432 cases) based on glucose tolerance status. In the general population, with the increase of HGI, LDL-C, non-HDL-C, and AIP gradually increased (all P values for trends were <0.05), and the proportion of abnormalities increased significantly (χ2=101.40, 42.91, 39.80; all P<0.001). A multivariate logistic regression model was established, which suggested a significant correlation between HGI and LDL-C, non-HDL-C, and AIP (all P<0.05), after adjusting for factors such as age, sex, fasting blood glucose, hypertension, body mass index, smoking, and alcohol consumption. In the overall population, normal glucose tolerance group, and diabetes group, HGI had the highest correlation with non-HDL-C (OR values of 1.325, 1.678, and 1.274, respectively); in the prediabetes group, HGI had a higher correlation with LDL-C (OR value: 1.510); and in different glucose metabolism groups, AIP and HGI were both correlated (OR: 1.208-1.250), but not superior to non-HDL-C and LDL-C. Conclusion: HGI was closely related to LDL-C, non HDL-C, and AIP in the entire population and people with different glucose metabolism, suggesting that HGI may be a predictor of atherosclerotic cardiovascular disease.
    目的: 研究血红蛋白糖化指数(HGI)与低密度脂蛋白胆固醇(LDL-C)、非高密度脂蛋白胆固醇(non-HDL-C)、血浆致动脉粥样硬化指数(AIP)等致动脉粥样硬化相关血脂指标的关系。 方法: 本研究为横断面研究,纳入2011年12月至2012年8月北京市苹果园社区参与调查的16 049名受试者,依据HGI三分位数分为低、中、高3组(分别为5 388、5 249、5 412人)。比较不同HGI组间致动脉粥样硬化相关血脂指标的差异,建立多因素logistics回归模型分析HGI与血脂指标异常的关联。按照不同糖代谢状态分层后,建立多因素logistics回归模型分析不同糖代谢人群中HGI与血脂指标的关系。 结果: 16 049名受试者平均年龄56岁,女性10 452人(65.1%),糖耐量正常9 093人、糖尿病前期4 524人、糖尿病2 432人。在总体人群中,随着HGI升高,LDL-C、non-HDL-C和AIP逐渐升高(趋势P值均<0.05),血脂异常患者比例均明显增加(χ2=101.40、42.91、39.80,均P<0.001)。多因素logistic回归模型提示,在校正了年龄、性别、空腹血糖、高血压、体重指数、吸烟、饮酒等因素后,HGI与LDL-C、non-HDL-C、AIP异常均具有显著相关性(均P<0.05),在总体人群、糖耐量正常人群、糖尿病人群中,HGI与non-HDL-C异常的相关性最高(OR=1.325、1.678、1.274);在糖尿病前期人群中,HGI与LDL-C异常的相关性更高(OR=1.510);不同糖代谢人群中,AIP异常与HGI均具有相关性(OR=1.208~1.250),但并不优于non-HDL-C和LDL-C。 结论: 在整体人群和不同糖代谢人群中,HGI与LDL-C、non-HDL-C和AIP等致动脉粥样硬化相关血脂指标密切相关,提示HGI可能是动脉粥样硬化性心血管疾病预测指标。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    头臂动脉屈曲是导致胸部X线异常的重要原因,类似于纵隔肿瘤。当胸部X光显示纵隔混浊异常时,应牢记血管异常的可能性。尤其是老年女性高血压患者。
    Buckling of the brachiocephalic artery is an important cause of unusual chest x-ray findings which resemble those of a mediastinal tumor. The possibility of a vascular anomaly should be kept in mind whenever a chest x-ray demonstrates an abnormal mediastinal opacity, especially in elderly female patients with hypertension.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号